Brief: Galera Therapeutics Co Received Letter From Nasdaq Stating That Co Had Regained Compliance
25/01/2023 22:48
Jan 25 (Reuters) - Galera Therapeutics Inc GRTX.O :
* GALERA THERAPEUTICS - ON JAN 24, CO RECEIVED LETTER FROM
NASDAQ
STATING THAT CO HAD REGAINED COMPLIANCE FOR CONTINUED LISTING
ON THE NASDAQ GLOBAL MARKET
Further company coverage: GRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Galera Therapeutics
See all newsBrief: Galera Therapeutics Says Nasdaq Will Delist Co's Common Stock By Filing Form 25 With SEC On Sept 4
Brief: Galera Announces Board Approval Of Complete Liquidation And Dissolution
Brief: Galera Therapeutics Receives Written Notice From Nasdaq Indicating That Nasdaq Hearings Panel Determined To Delist Co’s Shares
Brief: Alpha Pharma Investments Llc Reports 10.899% Passive Stake In Galera Therapeutics
Brief: Galera Adopts Limited Duration Stockholder Rights Agreement